Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-25-026203
Filing Date
2025-03-20
Accepted
2025-03-20 16:44:29
Documents
5
Effectiveness Date
2025-03-20

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm259819d1_s8.htm S-8 34456
2 EXHIBIT 5.1 tm259819d1_ex5-1.htm EX-5.1 60008
3 EXHIBIT 23.1 tm259819d1_ex23-1.htm EX-23.1 2102
4 EX-FILING FEES tm259819d1_ex-filingfees.htm EX-FILING FEES 15616
5 GRAPHIC tm259819d1_ex5-1img001.jpg GRAPHIC 8986
  Complete submission text file 0001104659-25-026203.txt   126021
Mailing Address UNIT 6-10, ZEUS BUILDING RUTHERFORD AVENUE, HARWELL DIDCOT X0 OX11 0DF
Business Address UNIT 6-10, ZEUS BUILDING RUTHERFORD AVENUE, HARWELL DIDCOT X0 OX11 0DF 44 (0) 1865 818808
Barinthus Biotherapeutics plc. (Filer) CIK: 0001828185 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-285968 | Film No.: 25757108
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)